16. May 2012 by admin.

News 10 new results for clinical trial

Clinical Trials Hope To Help Fight, Prevent Alzheimer’s NewsChannel5.com In a highly unusual move, researchers will focus this clinical trial on patients near Medellin, Colombia. Hundreds of people in one extended family were born with the genetic flaw that makes it certain they will contract Alzheimer’s by the age of 50. See all stories on this topic »

Trial will test whether drug curbs form of Alzheimer’s Boston Globe NEW YORK - In a clinical trial that could lead to treatments that prevent Alzheimer’s disease, people who are genetically guaranteed to suffer from the disease years from now - but who do not yet have any symptoms - will for the first time be given a … See all stories on this topic »

Applied Clinical Intelligence Launches iCommittees MarketWatch (press release) “Ultimately, our specialized technology and highly developed processes make better use of our clients’ clinical trial resources.” The arrival of iCommittees corresponds with a growing demand for DMC and EAC involvement in clinical research trials. See all stories on this topic »

Drug to prevent Alzheimer’s disease gets clinical trial Sarasota Herald-Tribune By The New York Times, Herald-Tribune In a clinical trial that could lead to treatments that prevent Alzheimer’s disease, people who are genetically guaranteed to suffer from the disease years from now — but who do not yet have any symptoms — will … See all stories on this topic »

Clinical drug trial facility opens in New Port Richey despite zoning objections Tampabay.com By Robert Napper, Times Correspondent NEW PORT RICHEY — A company that conducts clinical drug trials has opened its facility on Congress Street, in defiance of city officials who told them months ago that a rezoning would be required. See all stories on this topic »

NanoString Initiates Second Clinical Validation Study for Breast Cancer Assay MarketWatch (press release) SEATTLE, May 16, 2012 (BUSINESS WIRE) — NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the initiation of the second clinical validation … See all stories on this topic »

In Clinical Trials, Breath Test for Lung Cancer Shows Promise for Earlier … DARKDaily.com - Laboratory News First, researchers have completed the first clinical trial of a non-invasive cancer test that utilizes a breath specimen. Second, the subject of this clinical trial was lung cancer—a type of cancer that would benefit from a pathology test that can … See all stories on this topic » DARKDaily.com - Laboratory News

Onyx Pharmaceuticals Announces Data Presentations at 48th American Society of … MarketWatch (press release) The NDA submission is based on the Kyprolis 003-A1 study, an open-label, single-arm Phase 2b trial, as well as safety data from additional studies. A Phase 3 clinical trial, known as the ASPIRE trial, has completed enrollment and is evaluating the … See all stories on this topic »

One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And … Sacramento Bee The trial reported one-year clinical and six-month intravascular ultrasound (IVUS) outcomes data, evaluating the safety and effectiveness of the bioabsorbable abluminal polymer-coated SYNERGY Stent. Results were presented today at the annual EuroPCR … See all stories on this topic »

Roche to present studies on advanced cancers at ASCO Reuters ZURICH May 16 (Reuters) - Roche Holding AG will present late-stage clinical trial data on drugs targeting advanced cancers at a key industry event next month, as it seeks to prove it has enough armoury in its pipeline to protect its oncology franchise. See all stories on this topic »

Posted in News | No Comments »

10. May 2012 by admin.

Posted in News | No Comments »

2. May 2012 by admin.

News 10 new results for clinical trial

Clinical trials often fall short Mother Nature Network Most clinical trials for cancer, heart disease and mental health are too small to offer adequate medical evidence, said a review. By Agence France-PresseTue, May 01 2012 at 4:08 PM EST TRIALS: Ninety-six percent of those trials had fewer than 1000 … See all stories on this topic » Mother Nature Network

Clinical Trial Shows Sentra PM(R) Improves Quality of Sleep MarketWatch (press release) … Inc., a specialty pharmaceutical company that manufactures and distributes specialty pharmaceuticals to physicians, pharmacies and skilled nursing facilities, published results from a clinical trial of the proprietary medical food Sentra PM. See all stories on this topic »

Many Clinical Trials Unable to Supply High-Quality Evidence Medscape May 1, 2012 — Many interventional clinical trials are small, with significant heterogeneity in the methods used, including blinding, randomization, and the use of data monitoring committees (DMCs), according to a study of clinical trials registered at … See all stories on this topic »

NOVAVAX Launches Phase I Clinical Trial of A/H5N1 Influenza Vaccine Candidate MarketWatch (press release) ROCKVILLE, Md., May 2, 2012 (GlobeNewswire via COMTEX) — Novavax, Inc. (NASDAQ:NVAX) announced today that it has begun enrollment in a Phase I clinical trial of its monovalent virus-like particle (VLP) vaccine candidate to prevent a potential pandemic … See all stories on this topic »

Echo Therapeutics Announces Positive Clinical Trial Results of Symphony® tCGM … MarketWatch (press release) … wireless, transdermal continuous glucose monitoring system and its Prelude® SkinPrep System for transdermal drug delivery, today announced positive results from its clinical trial of the Symphony tCGM System in elective cardiac surgery patients. See all stories on this topic »

Verified Clinical Trials Presents at the Partnerships in Clinical Trials 2012 … Albany Times Union Verified Clinical Trials (VCT) a recognized expert in the field of dual enrollment in clinical trials presents at the Partnerships In Clinical Trials 2012 meeting to review the issues and definitive solutions regarding this serious problem. See all stories on this topic »

Analysis Finds Clinical Trials Often Small, of Poor Quality U.S. News & World Report By Randy Dotinga TUESDAY, May 1 (HealthDay News) — A new analysis of registered US clinical trials — the research that seeks to determine if medical treatments and prevention strategies work — finds that many are small and of poor quality. See all stories on this topic »

JAMA feature: Most clinical trials fail to add meaningful evidence Health Imaging If randomized controlled clinical trials are the gold standard for advancing knowledge in medical care, then the research community has been panning more particles than nuggets. That is the finding of a comprehensive analysis that focused on … See all stories on this topic »

ISR Profiles the State of Patient Recruitment in Clinical Trials MarketWatch (press release) CARY, NC, May 02, 2012 (BUSINESS WIRE) — Industry Standard Research (ISR) today announced the availability of a new report titled The State of Patient Recruitment in Clinical Trials that provides sponsors and service providers with valuable insight … See all stories on this topic »

Gilead Initiates Phase 3 Clinical Trial Evaluating GS-1101 for the Treatment … SunHerald.com Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the first patient has been dosed in a Phase 3 clinical trial evaluating the efficacy and safety of GS-1101 (formerly CAL-101). GS-1101 is an investigational, first-in-class specific inhibitor of … See all stories on this topic »

Web 2 new results for clinical trial

Clinical trials often fall short: U.S. study | The Raw Story That partnership, known as the Clinical Trials Transformation Initiative (CTTI), examined more than 96000 studies registered as of September 2010 with the … www.rawstory.com/rs/…/clinical-trials-often-fall-short-u-s-stud…

Clinical Trial on Promising PTSD Treatment Technology The study is the first trial in the United States, and one of only two trials in the world, testing … www.newswise.com/…/clinical-trial-on-promising-ptsd-treatme…

Posted in News | No Comments »

30. April 2012 by admin.

Posted in News | No Comments »

26. April 2012 by admin.

News 9 new results for clinical trial

PRC Clinical Selects SimpleCTMS Clinical Trial Management System MarketWatch (press release) OAKLAND, CA, Apr 25, 2012 (MARKETWIRE via COMTEX) — Trial By Fire Solutions, a leading eClinical solution provider specializing in clinical study management applications, today announced that PRC Clinical, a privately held Contract Research … See all stories on this topic »

How the FDA Stifles New Cures, Part II: 90% of Clinical Trial Costs are … Forbes “Stifling New Cures: The True Cost of Lengthy Clinical Trials,” by Avik Roy. Yesterday, the Manhattan Institute released a study I authored, entitled “Stifling New Cures: The True Cost of Lengthy Clinical Drug Trials.” (You can read the full report … See all stories on this topic » Forbes

AtheroNova Signs Agreement for Development of Clinical Trial Supplies MarketWatch (press release) Frontage CEO, Dr. Song Li, also commented on the agreement, stating “It is an honor to work with AtheroNova on this vital clinical trial materials project. Frontage’s 10-year history of delivering pharmaceutical R&D services in a fast and efficient … See all stories on this topic »

Repligen Reports Positive Results from Phase 1 Clinical Trial of RG3039 for … MarketWatch (press release) In addition to the Phase 1 clinical trial outcomes, the AAN presentation highlights the results of earlier mouse model studies conducted with RG3039 at Johns Hopkins University and in the lab of Dr. Chien-Ping Ko at University of Southern California. See all stories on this topic »

Repligen Reports Positive Results From Phase 1 Clinical Trial for Spinal … MarketWatch (press release) Repligen’s research efforts including this Phase 1 study have been partially supported by a grant from the Muscular Dystrophy Association (MDA). RG3039 is the first clinical-stage drug candidate to target the core genetic deficit in SMA in order to … See all stories on this topic »

CenterWatch launches online data library of the clinical research industry MarketWatch (press release) BOSTON, Apr 25, 2012 (BUSINESS WIRE) — CenterWatch, a leading provider of business information and market intelligence on the clinical research industry, announced today the release of its new online Data Library. The online resource features hundreds … See all stories on this topic »

Repligen Announces Favorable Results from Phase 1 Clinical Trial of … MarketWatch (press release) TUCSON, Ariz., April 25, 2012 /PRNewswire via COMTEX/ — Repligen Corp., in Waltham, Mass., announced today that its experimental drug RG3039, designed to treat spinal muscular atrophy (SMA), was safe and well-tolerated in a phase 1 clinical trial. See all stories on this topic »

Repligen Announces Favorable Results from Phase 1 Clinical Trial of … Sacramento Bee MDA awarded Repligen $1.4 million in December 2010 to support the advancement of RG3039 into phase 1 clinical trials. The award was made through MDA Venture Philanthropy (MVP), the drug development arm of MDA’s translational research program. See all stories on this topic »

NANOBODY FOR ALZHEIMER’S DISEASE FROM THE ALLIANCE WITH BOEHRINGER INGELHEIM … MarketWatch (press release) GHENT, Belgium, 25 April 2012 - Ablynx [Euronext Brussels: ABLX] today announced that Boehringer Ingelheim has submitted a Clinical Trials Application (CTA) to the European regulatory authorities to start a Phase I clinical trial with a Nanobody® for … See all stories on this topic »

Posted in News | No Comments »

9. April 2012 by admin.

News

Mytrus Rolls Out Clinical Research Industry’s First Patient-Friendly System … MarketWatch (press release) Using animation and other visual imagery, the Mytrus iPad application is the first in the industry to condense the complex and critical disclosure information required at the start of a clinical trial into an easy-to-understand, digitized format. See all stories on this topic »

Stealth Peptides Inc. Reports Results from Phase I Clinical Drug Interaction … MarketWatch (press release) BOSTON, Apr 09, 2012 (BUSINESS WIRE) — Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative therapies for diseases with unmet medical needs, announced today the results from three Phase I clinical trials of … See all stories on this topic »

Recurrent Prostate Cancer Treatment: Research Indicates New PHC Dietary … MarketWatch (press release) LOS ANGELES, April 9, 2012 /PRNewswire via COMTEX/ — Preliminary findings from an FDA-approved clinical trial indicate that the experimental dietary supplement Prostate Health Cocktail (PHC®) may arrest and in some cases lower rising PSA (Prostate … See all stories on this topic »

Achieve Clinical Research Is Conducting New Rheumatoid Arthritis Trials in … PR Web (press release) Achieve Clinical Research, located in Birmingham, AL, has started enrolling participants for a new Rheumatoid Arthritis clinical trial. The study is open to adults ages 18 - 75 who have been diagnosed with Rheumatoid Arthritis. See all stories on this topic » PR Web (press release)

Synergy Pharmaceuticals Achieves Halfway Mark in Enrollment on Plecanatide … MarketWatch (press release) “We are pleased with the vigorous pace of enrollment in this ongoing trial and the overall enthusiasm from the more than 100 clinical sites currently engaged in this clinical trial,” said Gary S. Jacob, Ph.D, President and Chief Executive Officer of … See all stories on this topic »

Indian clinical research firm looks to fill innovation gap ZDNet Asia Today, the Mumbai-headquartered clinical research organization (CRO) clocks revenue of about US$10 million and is targeting to increase this number to US$19.3 million by 2014. The company provides a range of services from new drug development to … See all stories on this topic » ZDNet Asia

ADVENTRX Announces Establishment of Regulatory Advisory Board MarketWatch (press release) We look forward to advancing ANX-188 into a phase 3 clinical trial later this year, and bringing the hope of a new therapy for sickle cell patients one step closer to fruition.” In his practice at Hyman, Phelps & McNamara, PC, Mr. Sasinowski assists … See all stories on this topic »

MusclePharm Announces Peer-Reviewed Publication Showing Positive Clinical … MarketWatch (press release) “Our findings suggest that Assault(TM) can provide athletes with an overall better workout experience by prolonging exercise performance, reducing fatigue and increasing energy-levels,” said Jordan R. Moon, Ph.D., lead researcher of the clinical trial … See all stories on this topic »

Clinical Notes: Insulin Analog Safe in Pregnancy MedPage Today A drug intended to boost production of dystrophin in patients with Duchenne muscular dystrophy actually did so in a small clinical trial, but no functional benefit was apparent, according to the drug’s manufacturer. The disease is caused by a variety … See all stories on this topic »

Targeted nanoparticles show success in clinical trials Next Big Future The nanoparticles feature a homing molecule that allows them to specifically attack cancer cells, and are the first such targeted particles to enter human clinical studies. Originally developed by researchers at MIT and Brigham and Women’s Hospital in … See all stories on this topic » Next Big Future

Posted in News | No Comments »

15. March 2012 by admin.

News

New Report Shows Illinois Clinical Trials Benefit State’s Health and Economy MarketWatch (press release) WASHINGTON, Mar 15, 2012 (BUSINESS WIRE) — Working in collaboration with Illinois’ university medical schools, hospitals and clinical research centers, the nation’s biopharmaceutical research companies are conducting or have conducted since 1999 … See all stories on this topic »

Almac’s Clinical Trial Workshop Series to Return in 2012 MarketWatch (press release) CRAIGAVON, Northern Ireland, Mar 15, 2012 (BUSINESS WIRE) — Almac will be hosting a series of complementary ‘lunch and learn’ style workshops across Europe and the US this spring tailored towards clinical trial / outsourcing professionals from … See all stories on this topic »

Completed Clinical Trial Further Indicates Cell-in-a-Box(R) Encapsulation … MarketWatch (press release) Although the original human clinical trials were limited to pancreatic cancer tumors, later work showed the Cell-in-a-Box(R)encapsulation technology has great potential for use in other solid tumors. The work also pointed toward encapsulated cells … See all stories on this topic »

Ottawa researchers to lead world-first clinical trial of stem cell therapy for … PhysOrg.com (press release) Dr. Lauralyn McIntyre of the Ottawa Hospital Research Institute and the University of Ottawa has been awarded more than $400000 from the Canadian Institutes of Health Research and the Stem Cell Network to lead the first clinical trial in the world of a … See all stories on this topic » PhysOrg.com (press release)

Research and Markets: Nicotine Addiction Global Clinical Trials Review, H1, 2012 SunHerald.com DUBLIN — Dublin - Research and Markets (http://www.researchandmarkets.com/research/0d7f8f46/nicotine_addiction) has announced the addition of GlobalData’s new report “Nicotine Addiction Global Clinical Trials Review, H1, 2012″ to their offering. See all stories on this topic »

DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results … MarketWatch (press release) CLEVELAND, March 15, 2012 /PRNewswire via COMTEX/ — DATATRAK International, Inc. (otcqx:DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced its operating results for the … See all stories on this topic »

Endocyte jumps on plans for cancer drug candidate msnbc.com NEW YORK — Shares of Endocyte Inc. skyrocketed Wednesday after the company said it is close to restarting a clinical trial of an experimental cancer drug, as well as filing for conditional marketing approval in Europe. Don’t miss these Health stories … See all stories on this topic »

Hep C vaccine heads into further clinical trials FierceVaccines Okairos, a spinout from Merck ($MRK), is starting a Phase I/II clinical trial for its preventive hep C vaccine for people at risk of infection that it says is the first multi-center, double-blinded, randomized, placebo-controlled trial of a vaccine to … See all stories on this topic »

Cytomedix Announces Publication in American Heart Journal Highlighting … MarketWatch (press release) “We are very encouraged by these positive data as they corroborate both the preclinical research and other clinical studies that suggest ALDH(br) cells specifically migrate to sites of ischemic damage and induce the formation of new blood vessels at … See all stories on this topic »

Oncolytics Biotech® Inc. Announces 2011 Year End Results MarketWatch (press release) “In the last year we made substantial progress as we announced positive clinical trial results and started clinical trials in additional cancer indications while maintaining the strength of our balance sheet,” said Dr. Brad Thompson, President and CEO … See all stories on this topic »

Posted in News | No Comments »

14. March 2012 by admin.

News

MolecularHealth Names Drug Safety and Personalized Medicine Expert Lawrence J … MarketWatch (press release) He was also a faculty member at the University of Massachusetts Medical Center and the Massachusetts College of Pharmacy. Dr. Lesko is a Fellow of the American College of Clinical Pharmacology, the American Association of Pharmaceutical Sciences and … See all stories on this topic »

Local medical companies and schools sponsor new exhibit at GWIZ Science Center … Bradenton Herald Meduzone consists of a career zone, interactive zone, operation simulation area, 3D learning zone, medical artifacts and a computer quiz area. Several local medical companies and colleges collaborated and sponsored the exhibit. The Manatee and Sarasota … See all stories on this topic » Bradenton Herald

Michigan teen’s breast cancer research nets him $100000 1st-place science prize Detroit Free Press By Todd Spangler On Tuesday night, Nithin, a 17-year-old senior at Port Huron Northern High School, won the $100000 first prize in the Intel Science Talent Search, the first Michigander to do so in the 70-year history of the competition. See all stories on this topic »

Media Advisory - 2012 Canada Gairdner Awards to be Unveiled March 21 MarketWatch (press release) A source of national pride, the Awards are a major indicator of leading scientific discovery. Over the past 10 years, 18 of 27 Nobel Prize in Medicine winners had previously received a Canada Gairdner Award. In fact, one in four of all Canada Gairdner … See all stories on this topic »

Columbia and Weill Cornell Join National Effort to Spur Clinical Trials in the … Newswise (press release) Newswise — The National Institute for Neurological Disorders and Stroke (NINDS) has selected Columbia University College of Physicians and Surgeons and Weill Cornell Medical College to participate in a new national effort to accelerate the development … See all stories on this topic »

Joco Research Triangle at last is a dream come true Kansas City Star The University of Kansas wanted more classroom space to expand business, engineering, science and technology programs for undergraduates and graduates on its Edwards campus in Overland Park. KU’s School of Medicine needed a cozy spot to test drugs and … See all stories on this topic »

Med School rankings rise in primary care, fall in research The Brown Daily Herald The report released rankings for graduate programs in computer science, engineering, humanities, medical education and the sciences. Medical schools are ranked in two main categories — expertise in primary care for patients and research. See all stories on this topic »

South Meck to launch new medical training Charlotte Observer By Caroline McMillan A new high school biomedical science program offered through “Project Lead the Way” will introduce students to human medicine, physiology, genetics, microbiology and public health. South Mecklenburg High School’s new biomedical … See all stories on this topic »

Nova Scotia’s Immunovaccine partners with US college in addiction research TheChronicleHerald.ca A Nova Scotia biotechnology company has inked a deal with a prestigious American medical research college. Immunovaccine Inc. has partnered with Weill Cornell Medical College in New York City to bolster a promising vaccine for treating cocaine … See all stories on this topic »

Teenager Unlocks Potential Pathways for Breast Cancer Treatments, Wins Intel … MarketWatch (press release) –The Intel Science Talent Search, the nation’s oldest and most prestigious pre-college science and math competition, recognizes 40 high school seniors who are poised to be the next leaders in innovation and help solve some of the world’s greatest … See all stories on this topic »

Posted in News | No Comments »

9. March 2012 by admin.

Posted in News | No Comments »

2. March 2012 by admin.

Posted in News | No Comments »